A rare human variant that disrupts GPR10 signalling causes weight gain in mice.
Fleur TalbotClaire H FeethamJacek MokrosinskiKatherine L LawlerJulia M KeoghElana HenningEdson Mendes de OliveiraVikram AyinampudiSadia SaeedAmélie BonnefondMohammed ArslanGiles S H YeoPhillippe FroguelDavid A BechtoldAntony D AdamsonNeil HumphreysInês A BarrosoSimon M LuckmanDavid R FitzPatrickPublished in: Nature communications (2023)
Disruption of brain-expressed G protein-coupled receptor-10 (GPR10) causes obesity in animals. Here, we identify multiple rare variants in GPR10 in people with severe obesity and in normal weight controls. These variants impair ligand binding and G protein-dependent signalling in cells. Transgenic mice harbouring a loss of function GPR10 variant found in an individual with obesity, gain excessive weight due to decreased energy expenditure rather than increased food intake. This evidence supports a role for GPR10 in human energy homeostasis. Therapeutic targeting of GPR10 may represent an effective weight-loss strategy.
Keyphrases
- weight gain
- weight loss
- body mass index
- birth weight
- fatty acid
- bariatric surgery
- endothelial cells
- roux en y gastric bypass
- high fat diet induced
- gastric bypass
- insulin resistance
- type diabetes
- metabolic syndrome
- induced apoptosis
- copy number
- glycemic control
- pluripotent stem cells
- resting state
- signaling pathway
- cancer therapy
- functional connectivity
- cell cycle arrest
- early onset
- oxidative stress
- brain injury
- cerebral ischemia